Recent studies reveal UBQLN2’s role in accelerating α-synuclein aggregation through liquid-liquid phase separation, offering new therapeutic targets for Parkinson’s disease and related ne...
The Phase 3 failure of semaglutide in Alzheimer’s disease highlights challenges in repurposing GLP-1 agonists, urging a shift towards biomarker-driven and personalized approaches in neurodegener...
Exploring the dual impact of digital technology on mental health, from screen-time anxiety to AI-driven mindfulness apps, with evidence-based strategies for balance. Digital technology’s rise re...
Analytical post on plant-based diets, highlighting recent studies from JAMA and WHO, environmental benefits per UNEP, and market trends with NielsenIQ data. Exploring how plant-based diets reduce chro...
This analysis explores how digital technology affects mental health, highlighting recent studies, corporate responsibilities, and regulatory efforts, with actionable tips for balance. Excessive screen...
Plant-based diets gain momentum with studies showing lower chronic disease risks and environmental benefits, reshaping global food industries and consumer habits through innovation and policy. New res...
A new study demonstrates that CAR regulatory T cells targeting oxidized LDL can cut atherosclerotic plaque by 70% in mice, offering a potential one-time therapy for cardiovascular disease prevention. ...
MoS2 nanoflowers boost mitochondrial biogenesis in mesenchymal stem cells, improving treatment for age-related diseases without genetic engineering, based on a 2023 Advanced Materials study. New resea...
The Muse headband uses EEG and fNIRS for real-time neurofeedback, enhancing meditation, focus, and sleep. Backed by Mayo Clinic research, it reduces stress and aids ADHD management through personalize...
Recent Swedish research shows long-term exposure to PM2.5, PM10, and NOx elevates sarcopenia risk in seniors via chronic inflammation, urging public health interventions for aging populations. A Swedi...
